Nippon Life Insurance’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-82,129
Closed -$6.65M 138
2017
Q3
$6.65M Buy
82,129
+1,021
+1% +$78.1K 0.12% 46
2017
Q2
$5.74M Buy
81,108
+15,063
+23% +$1M 0.11% 51
2017
Q1
$4.49M Buy
66,045
+7,775
+13% +$547K 0.09% 63
2016
Q4
$4.17M Buy
58,270
+386
+0.7% +$28.7K 0.08% 66
2016
Q3
$4.58M Buy
57,884
+202
+0.4% +$16.4K 0.1% 61
2016
Q2
$4.81M Sell
57,682
-6,926
-11% -$615K 0.12% 55
2016
Q1
$5.93M Buy
64,608
+2,309
+4% +$208K 0.15% 45
2015
Q4
$6.3M Sell
62,299
-2,772
-4% -$288K 0.16% 45
2015
Q3
$6.39M Sell
65,071
-4,059
-6% -$451K 0.17% 43
2015
Q2
$8.09M Sell
69,130
-4,195
-6% -$458K 0.2% 36
2015
Q1
$7.2M Sell
73,325
-2,281
-3% -$232K 0.18% 39
2014
Q4
$7.13M Sell
75,606
-1,753
-2% -$181K 0.18% 46
2014
Q3
$8.23M Sell
77,359
-6,007
-7% -$588K 0.21% 37
2014
Q2
$6.91M Sell
83,366
-8,200
-9% -$638K 0.18% 42
2014
Q1
$6.49M Sell
91,566
-11,701
-11% -$918K 0.18% 47
2013
Q4
$7.76M Sell
103,267
-2,841
-3% -$198K 0.22% 40
2013
Q3
$6.67M Sell
106,108
-19,483
-16% -$1.16M 0.21% 44
2013
Q2
$6.43M Buy
+125,591
New +$6.55M 0.21% 45

Other funds holding GILD

Nippon Life Insurance's GILD Position: Q4 2017 in Review

Nippon Life Insurance sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 82,129 shares — an estimated $6.65M sold.

Nippon Life Insurance first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $8.23M in Q3 2014. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Nippon Life Insurance reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Nippon Life Insurance sold 82,129 Gilead Sciences shares in Q4 2017, an estimated $6.65M.
  • Nippon Life Insurance first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • Nippon Life Insurance's Gilead Sciences position peaked at $8.23M in Q3 2014.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Nippon Life Insurance's 13F filing for Q4 2017, filed 13 Feb 2018.